Unknown

Dataset Information

0

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.


ABSTRACT: Concomitant platinum-based chemotherapy and radiotherapy (CT-RT) is the recommended treatment for unresectable locally advanced stage III non-small cell lung cancer (NSCLC). We conducted a phase II study to evaluate the efficacy and safety of fractionated oral vinorelbine with cisplatin as induction CT followed by CT-RT.Patients with stage III NSCLC received 2 induction cycles of intravenous vinorelbine 25 mg/m2 and cisplatin 80 mg/m2 on day 1 and oral vinorelbine 60 mg/m2 on day 8. Responding patients received 2 more cycles of cisplatin 80 mg/m2 on day 1 and oral vinorelbine 20 mg on days 1, 3 and 5 concomitantly with radiotherapy 2 Gy daily, 5 days/week for a total of 66 Gy.Seventy patients, median age 61 years, were enrolled. Overall response rate (ORR) was 50.0%; Disease Control Rate was 81.42%. Median PFS was 14.58 months [95% CI, 10.97-18.75]. Median OS was 17.08 months [95% CI, 13.57-29.57]. One-year and 2-year survival rates were 68.6% [95% CI, 57.7-79.4] and 37%. One patient had a grade 3 pulmonary radiation injury and 26.5% had graded 1/2 esophagitis.In non-operable IIIA-IIIB NSCLC, the combination oral vinorelbine (fractionated fixed dose) plus cisplatin, during concomitant CT-RT, could offer a well-tolerated option, with comparable activity to I.V. vinorelbine-based chemoradiotherapy regimens.ClinicalTrials.gov, NCT01839032.

SUBMITTER: Lerouge D 

PROVIDER: S-EPMC3986598 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.

Lerouge Delphine D   Rivière Alain A   Dansin Eric E   Chouaid Christos C   Dujon Cécile C   Schott Roland R   Lavole Armelle A   Le Pennec Vincent V   Fabre Elizabeth E   Crequit Jacky J   Martin Francis F   Dehette Stéphanie S   Fournel Pierre P   Precheur-Agulhon Bénédicte B   Lartigau Eric E   Zalcman Gérard G  

BMC cancer 20140330


<h4>Background</h4>Concomitant platinum-based chemotherapy and radiotherapy (CT-RT) is the recommended treatment for unresectable locally advanced stage III non-small cell lung cancer (NSCLC). We conducted a phase II study to evaluate the efficacy and safety of fractionated oral vinorelbine with cisplatin as induction CT followed by CT-RT.<h4>Methods</h4>Patients with stage III NSCLC received 2 induction cycles of intravenous vinorelbine 25 mg/m2 and cisplatin 80 mg/m2 on day 1 and oral vinorelb  ...[more]

Similar Datasets

| S-EPMC7666785 | biostudies-literature
| S-EPMC6491187 | biostudies-literature
| S-EPMC5870479 | biostudies-literature
| S-EPMC8009170 | biostudies-literature
| S-EPMC5381116 | biostudies-literature
| S-EPMC4740006 | biostudies-literature
| S-EPMC5847001 | biostudies-literature
| S-EPMC5569675 | biostudies-literature
| S-EPMC7871351 | biostudies-literature
| S-EPMC10864194 | biostudies-literature